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Abstract
Background: To assess the utility of haplotype association mapping (HAM) as a quantitative trait
locus (QTL) discovery tool, we conducted HAM analyses for red blood cell count (RBC) and high
density lipoprotein cholesterol (HDL) in mice. We then experimentally tested each HAM QTL
using published crosses or new F2 intercrosses guided by the haplotype at the HAM peaks.
Results: The HAM for RBC, using 33 classic inbred lines, revealed 8 QTLs; 2 of these were true
positives as shown by published crosses. A HAM-guided (C57BL/6J × CBA/J)F2 intercross we
carried out verified 2 more as true positives and 4 as false positives. The HAM for HDL, using 81
strains including recombinant inbred lines and chromosome substitution strains, detected 46 QTLs.
Of these, 36 were true positives as shown by published crosses. A HAM-guided (C57BL/6J × A/
J)F2 intercross that we carried out verified 2 more as true positives and 8 as false positives. By
testing each HAM QTL for RBC and HDL, we demonstrated that 78% of the 54 HAM peaks were
true positives and 22% were false positives. Interestingly, all false positives were in significant allelic
association with one or more real QTL.
Conclusion: Because type I errors (false positives) can be detected experimentally, we conclude
that HAM is useful for QTL detection and narrowing. We advocate the powerful and economical
combined approach demonstrated here: the use of HAM for QTL discovery, followed by mitigation
of the false positive problem by testing the HAM-predicted QTLs with small HAM-guided
experimental crosses.
Background
Model organisms facilitate the discovery of genes through
classical experimental methodologies and, more recently,
through the application of bioinformatics resources and
tools. Inbred line crosses have been successfully uncover-
ing quantitative trait loci (QTLs) of complex traits since
the early 1990's [see review in [1]]. Meanwhile, vast
improvements in high-throughput methodologies and
the resulting availability of genomic data such as genome-
wide sequence coverage, single nucleotide polymorphism
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have enhanced the capabilities of classical model organ-
ism research. The molecular dissection of complex traits is
aided by harnessing these increasingly accessible data
through the integration of bioinformatics into traditional
methods of gene discovery [2-4].
In silico QTL mapping, or as we prefer to call it, haplotype
association mapping (HAM), has been proposed as a
means of utilizing phenotypic data from inbred strains
together with dense marker maps to determine associa-
tions of haplotypes with phenotypes [5,6]. Initially this
approach was highly criticized on the one hand as having
too many statistical issues to be useful, such as a high rate
of false positives that could lead to much dead end work
[7], while on the other hand it was welcomed with exces-
sive zeal as the end to tedious and expensive experimental
crosses [5].
Subsequent reports have tempered these two 2 perspec-
tives somewhat with investigations of the power of HAM
when variables and algorithms are altered, such as the
number of strains, the "population structure" of the strain
panel, the density of markers, the size of the haplotypes,
the haplotype inference method, and efforts to control
family-wise error [6,8-11]. In addition, some researchers
have found HAM useful as part of an integrative fine-map-
ping method for narrowing known QTLs [12,13] or as a
method for QTL discovery [14,15], while others have
found that the method lacks power for their phenotype of
interest [16].
Understanding the conditions under which HAM suc-
ceeds or fails to identify QTLs and the mechanisms by
which type I errors (false positives) and type II errors
(false negatives) are generated will help researchers wisely
use this powerful tool. The number and the genetic relat-
edness of the inbred strains used in HAM analyses are
known to affect its statistical power [8,9,17,18]. In addi-
tion, it has been noted that spurious associations among
both linked (cis) and unlinked markers (trans) are likely to
be a problem in association studies such as HAM
[7,10,12].
In this study, we evaluated the performance of HAM as a
tool for discovering and mapping QTLs. We used it to pre-
dict QTLs for red blood cell count (RBC) and for plasma
concentration of high density lipoprotein cholesterol
(HDL) in mice. We then tested whether each HAM-pre-
dicted QTL was a real QTL, as determined by a previously
reported QTL cross that fit the haplotype at the HAM-pre-
dicted QTL peak or by a new cross carried out specifically
to test these HAM-predicted QTLs. Our results, which
allowed us to calculate the rate of false positives, show
that HAM can be a powerful, although not comprehen-
sive, predictor of QTLs even for a highly polygenic trait
such as HDL cholesterol. We also show that extensive
allelic association, the matching of SNPs at true HAM
peaks with SNPs elsewhere in the genome, is responsible
for type I error control problems; and we demonstrate a
method for mitigating this issue that involves conducting
relatively small-scale experimental crosses to test HAM
QTL peaks.
Results
RBC - red blood cell count
HAM - Haplotype association mapping
With the trait of red blood cell count, our goal was to
assess the usefulness of HAM in discovering new QTLs
when working on a quantitative trait for which little was
known about its genetic architecture. Haplotype associa-
tion mapping of 33 classic inbred strains for RBC in
females (Figure 1) yielded one significant peak on chro-
mosome (Chr) 2 and 7 suggestive peaks on Chrs 1, 4, 7,
11, 12, and 15 (see Table 1). Here, we defined a HAM
"peak" as the individual SNP plus the consecutive 2 SNPs
that make up its 3-SNP window (see Methods). Because
each unique QTL may be surrounded by SNPs that also
were above the level of significance, we have included a
column in Table 1 that shows the range of SNPs surround-
ing the HAM peak that are below the suggestive signifi-
cance of 0.63. For some QTL, such on the one on Chr 1,
only the single SNP window reached suggestive signifi-
cance, but for the QTL on Chr 2, this range is so large
(116-131 Mb) that we suspect a second QTL gene may
exist in the region.
(B6 × CBA)F2 intercross
The next question is which of these 8 HAM-detected peaks
detected at a significance of 0.63 represents a true peak
and which are false positives. To answer that question, we
first examined the literature for red blood cell QTLs and
found that 2 of these QTLs on Chrs 4 and 11 have been
detected previously with classic inbred line crosses and
the haplotype at the HAM peaks differed for the parental
strains that detected the QTL [19]; thus these 2 are true
positives. To determine whether the remaining 6 peaks are
true or false positives, we tested them with a small haplo-
type-based intercross. At each of the 6 peaks, we deter-
mined the haplotypes, examined which pair of strains
would be expected to have a QTL peak at that location,
and then carried out a cross between CBA and C57BL/6J
(B6) because those 2 strains would be able to detect all 6
QTLs if they were true positives. Because we were only
testing these 6 locations, we used a small cross of 108
mice and only tested polymorphic markers at or flanking
each of the 6 peaks to determine whether the polymor-
phisms were associated with a difference in phenotype.
One-way ANOVAs conducted at markers near, including,
or flanking the 6 HAM peaks revealed that the significant
peak on Chr 2 (124.8 Mb) and the suggestive peak on ChrPage 2 of 12
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(Figure 2). The remaining 4 peaks tested (Chr 1: 32.9 Mb,
Chr 7: 24.4 Mb, Chr 11: 116.5 Mb, and Chr 15: 100.6 Mb)
were not significantly correlated with RBC (data not
shown), so we classified these as "false positives" (Table
2). If one uses a suggestive level of 0.63, this gives a false
positive rate of 50% (4 of 8); if we had used a more strin-
gent suggestive level of 0.20, there would have been no
false positives for any of the 3 loci detected at this level.
However, one true positive on Chr 11 would have been
lost.
Allelic association analysis
We then tested each false positive locus to determine if it
was in allelic association with the experimentally verified
HAM QTLs. We used the common statistical test for link-
age disequilbrium, which is the same as allelic association
except that linkage disequilbrium is restricted to loci on
the same chromosome. We tested the non-independence
of the false positive HAM peaks by examining the pairwise
allelic association among all of the peaks for RBC (Figure
3). All "clusters" of SNPs within a chromosomal peak
were found to be in significant linkage disequilbrium with
each other, including the cluster of spread out peaks from
116.3 Mb to 131.3 Mb on Chr 2. In addition, the false
positives on Chrs 7, 11, and 15 were in significant allelic
association with at least one real QTL (Figure 3). The Chr
7 and Chr 11 false positive peaks were in allelic associa-
tion with both the novel HAM QTL on Chr 2 and with the
HAM QTL within the known QTL on Chr 11 [19] detected
by a (NZW × SM)F2 intercross. The Chr 15 false positive
was in allelic association with the HAM QTL on Chr 12.
Only the Chr 1 false positive was not in significant allelic
association with any other HAM peaks after a conservative
Bonferroni correction for multiple tests.
HDL - high density lipoprotein cholesterol
HAM - haplotype association mapping
Using the trait of HDL cholesterol, our goal was to assess
the usefulness of HAM for a quantitative trait with highly
HAM genome scan for RBC in 33 inbred lines of miceFigure 1
HAM genome scan for RBC in 33 inbred lines of mice. X-axis = position in genome, chromosomes labeled. Y-axis = 
uncorrected HAM score, which is -log10(P value). Dotted lines indicate thresholds of genome-wide significance; HAM scores 
are 4.97, 4.34, and 3.64 for P = 0.05, 0.20, and 0.63.
Table 1: RBC HAM QTL peaks
Chr SNP ID Mb Range HAM Bootstrap P
1 rs13475796 32,907,323 - 3.89 73.4% P < 0.63
2 rs6257970 124,821,501 116,276,771-131,106,484 5.10 94.8% P < 0.05
4 rs3664701 105,717,060 105,385,114-105,717,060 4.60 88.5% P < 0.20
7 rs13479152 24,436,399 24,248,444-24,436,399 4.10 75.9% P < 0.63
11 rs13481145 88,251,886 - 3.87 79.2% P < 0.63
11 rs3024036 116,489,336 116,489,336-116,486,660 3.68 65.5% P < 0.63
12 rs13481527 73,806,035 72,236,752-74,576,810 4.92 96.2% P < 0.20
15 rs3023430 100,626,402 - 3.74 68.5% P < 0.63
HAM QTL information for significant (P < 0.05), highly suggestive (P < 0.20), and suggestive (P < 0.63) RBC peaks at HAM scores of 4.97, 4.34, and 
3.64 respectively. HAM score is -log P value. Positions are based on NCBI Mouse Build 36 position (bp) of 1st SNP in 3-SNP window. The range is 
the locations of first and last SNP surrounding the peak that had a value <0.63. Boldface highlights peaks with P < 0.20 significance level.Page 3 of 12
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influence HDL cholesterol levels in mice as estimated
from the 111 HDL QTLs identified by over 24 different
inbred line crosses [20,21]. Because no peaks reached the
genome-wide significance threshold when we performed
HAM for HDL with only the 33 classic inbred strains (data
not shown), we added the chromosome substitution
strains derived from strains B6 and A/J and 2 sets of
recombinant inbred lines (AXB, BXD) for a total of 81
strains (see Methods). While this expanded strain panel
increased the power of peak detection (Figure 4), it also
brought with it additional potential for false positives due
to the enrichment of the B6, A/J, and DBA/2 genomes
contributed by the consomic and recombinant inbred
lines. This HAM yielded 46 peaks significant at the 0.05
level (Table 3). The range in Table 3 represents any SNPs
surrounding the peak that also had a significance level
<0.05.
Testing for true positive peaks
As shown in Table 3, 36 of these 46 HAM peaks were true
positives because they were detected previously in inbred
line crosses [20,21] and because the haplotype at the
HAM peaks differed for the parental strains that detected
the QTL. To test whether the remaining 10 peaks were true
or false positives, we tested them with a haplotype-based
intercross as we did for RBC. At each of the 10 peaks, we
determined the haplotypes, examined which pair of
strains would be expected to have a QTL peak at that loca-
tion, and then carried out a cross between B6 and A/J
because those 2 strains would be able to detect all 10 QTLs
if they were true positives. We tested polymorphic mark-
ers at only those 10 peaks to determine if a true QTL
existed.
One-way ANOVAs revealed that 2 peaks (Chr 8: 36 Mb
and Chr 8: 68 Mb) are significantly correlated with HDL
(Figure 5). The other 8 peaks (Chr 2: 3 and 8 Mb; Chr 3:
147 and 151; Chr 10: 28, 59, and 66 Mb; Chr 13: 118 Mb)
failed to show a phenotype-genotype correlation (data
not shown), confirming that they are indeed HAM false
positives, yielding a 17% false positive rate for this trait
under these mapping conditions.
False negatives
Since most inbred line crosses conducted now re-find
HDL QTLs mapped previously by other crosses, we feel
that the QTL map for HDL is almost saturated. This allows
us to ask the question of false negatives -- whether HAM
Significant one-way ANOVAs for RBC in (CBA × B6)F2 femalesFigure 2
Significant one-way ANOVAs for RBC in (CBA × B6)F2 females. RBC measured as number of cells per microliter (n/
uL). BB are B6 homozoygotes, BC are heterozygotes, and CC are CBA homozygotes. A. Chr 2 ANOVA at 125.4 Mb (marker 
SNP = rs6324984, P = 0.029). B. Chr 12 ANOVA at 73.6 Mb (marker SNP = rs3714720, P = 0.0075).
Table 2: Testing whether the RBC HAM peaks are true or false 
positives
Chr Mb True/false Evidence for QTL Reference
1 32.9 False None in CBAxB6 This report
2 124.8 True QTL in CBAxB6 This report
4 107.7 True QTL in NZWxSM 19
7 24.4 False None in CBAxB6 This report
11 88.2 True QTL in NZWxSM 19
11 116.4 False None in CBAxB6 This report
12 73.8 True QTL in CBAxB6 This report
15 100.6 False None in CBAxB6 This reportPage 4 of 12
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we mapped the 95% confidence intervals of HDL QTLs
for each inbred line cross onto a physical map and indi-
cated the peak locations of the 46 HAM peaks (Figure 6).
This figure has boxes around the 2 new QTL peaks on Chr
8 detected first by HAM and then confirmed by the inter-
cross described above. It also has ovals around the false
positives on Chr 2, 3, 10, and 13. The gray bars indicate
known QTLs as determined by crosses; several of these
have no HAM peaks (Chrs 1, 3, 4, distal 6, 7, 10, distal 14,
17 and 19) indicating a number of false negatives or QTLs
that were not detected by the HAM analysis. Calculating a
false negative rate is uncertain because some of these
regions may contain more than one QTL. However, there
are at least 12 QTL regions that were not detected by HAM.
If we add these 12 to the 38 true positives, that provides a
total of 50 QTLs; since 12 were missed by HAM, the lowest
estimate of a false negataive rate is 24% (12/50).
Allelic association analysis
We tested each of the 8 false positive loci for HDL to deter-
mine if each was in allelic association with experimentally
verified HAM peaks. After testing for pairwise correlations,
we found that all false positives were in allelic association
with real HAM QTLs on multiple chromosomes
(Figure 7).
Discussion
Haplotype association mapping was developed as a tool
for quantitative trait analysis. Initially conceived as an
inexpensive and rapid alternative to intercrosses for find-
ing QTLs, limitations of statistical power and type I error
control have restricted its widespread adoption. Whereas
other studies have suggested that HAM be included in an
approach to dissecting complex traits that involves haplo-
type association mapping within known QTLs [12,22], we
demonstrate here the additional proficiency of HAM in
detecting novel QTLs. We show that using genome-wide
HAM to predict QTLs and then testing the novel QTLs by
small haplotype-guided intercrosses can successfully pin-
point QTLs, even for highly complex traits like HDL cho-
lesterol. We also prove the role of allelic association in
HAM's pervasive false positive problem in laboratory
mice, an issue mitigated by our method of testing HAM-
predicted QTLs in small crosses. Detecting QTLs by HAM
is a balance between reducing missed QTLs (false nega-
tives, or type II errors) while increasing false positives
(type I errors), and increasing missed QTLs while reducing
false positives. However, because one well-chosen and rel-
atively small cross can test many HAM QTL peaks using
only targeted genotyping, we feel that it is better to err on
the side of reducing the missed QTLs while increasing the
false positives.
Overall, combining the results of RBC and HDL, we found
12 of 54 HAM peaks were false positives. This may be an
underestimate since some of the "true positives" con-
firmed by previous crosses may not actually be true. We
think this particularly likely if 2 HAM peaks are close
together such as those on distal Chr 8 or proximal Chr 14.
Only identification of the QTL genes will show whether
such closely linked QTL peaks are both real. We estimate
a false positive rate of 24%, a number that is almost cer-
tainly an underestimate and highly dependent on the
number of strains used.
Using HAM, even quantitative traits with completely
unknown or little-known genetic architecture can be eco-
nomically explored. An example is the exploration of red
blood cell count reported here. Using one HAM-directed
small-scale experimental cross with targeted genotyping,
we discovered 2 novel RBC QTLs, including a QTL on Chr
2 that includes a strong candidate gene for red blood cell
count. The parental strains of the RBC test cross were
based solely on their haplotype differences at the RBC
HAM peaks and, in fact, are not very different in terms of
mean RBC count (units per volume × 106 [n/uL]) with the
mean RBC for B6 at 9.186 n/uL and the mean RBC for
CBA at 9.232 n/uL. Upon testing the F2 progeny from this
cross, we confirmed the presence of RBC QTLs on Chrs 2
and 12, which represent QTLs not yet found by traditional
crosses. Furthermore, a cursory examination of the genes
underlying the Chr 2 HAM QTL reveals a likely candidate
gene, erythrocyte protein band 4.2 (Epb4.2). EPB42 is a
major component of the erythrocyte membrane skeletal
network that regulates the stability and flexibility of eryth-
rocytes, and is implicated in the maintenance of normal
surface area and cation transport in red blood cells [23-
25]. As further evidence that it is the likely quantitative
trait gene underlying this novel QTL for red blood cell
Allelic association among RBC HAM peaksFigure 3
Allelic association among RBC HAM peaks. Allelic 
association among false positive RBC HAM peaks (on left) 
and true RBC HAM QTLs (on right).Page 5 of 12
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in hemolytic anemias of varying severity [26].
Our results agree with the report of lung tumor suscepti-
bility phenotypes [22], which used HAM to find QTL
peaks and then used previously published crosses to
determine whether the peaks were true or false. Our report
goes somewhat further in using the haplotypes at the
HAM-predicted peaks to carry out a small cross designed
to test each of the peaks not previously found. Since we
conducted the HAM analysis and then carried out the
crosses to test novel peaks, a number of advances that will
improve HAM and reduce the false positives have
occurred. The density of the SNP maps and the number of
Table 3: Significant HDL HAM QTL peaks (P < 0.05)
Chr SNP ID Mb Range HAM bootstrap True/false Ref
2 rs6220817 3,011,010 - 6.30 76.2% False a
2 rs13476342 8,836,883 - 6.43 75.8% False a
2 rs13476342 99,935,969 98,155,571-100,911,329 6.58 77.4% True 20,21
2 rs13476760 126,832,982 126,336,525-126,832,982 5.74 65.6% True 20,21
2 rs13476760 135,828,607 - 5.84 63.0% True 20,21
3 rs13477475 147,010,573 - 6.03 62.4% False a
3 rs13477475 151,010,779 - 6.62 77.8% False a
4 rs3693400 146,890,343 - 5.89 69.2% True 20,21
5 rs3693400 55,019,679 54,974,352-55,019,679 5.67 58.2% True 20,21
5 rs6265085 65,029,889 65,029,889-65,818,061 6.64 80.5% True 20,21
5 rs6265085 74,887,607 - 5.57 61.3% True 20,21
5 rs13478349 80,970,712 80,945,292-80,970,712 7.21 87.4% True 20,21
5 rs13478349 84,064,324 - 5.85 60.8% True 20,21
5 rs13460234 91,625,499 - 5.87 66.6% True 20,21
5 rs13460234 97,622,792 - 5.49 57.1% True 20,21
5 rs3668978 130,797,661 - 5.94 60.6% True 20,21
5 rs3668978 140,694,495 139,748,376-140,870,443 5.98 67.5% True 20,21
6 rs13478802 66,337,104 65,537,646-66,337,104 6.11 70.0% True 20,21
8 rs13478802 36,795,544 - 5.77 61.6% True a
8 rs13479806 68,181,411 - 5.67 62.4% True a
8 rs13479806 100,597,759 - 5.78 68.0% True b
8 rs13479951 103,466,389 - 5.50 62.7% True b
9 rs13479951 40,786,256 40,599,802-41,263,933 5.67 70.7% True 20,21
9 rs4227694 58,060,520 - 5.67 62.8% True 20,21
10 rs4227694 28,727,018 - 5.54 58.2% False a
10 rs13480621 59,831,809 - 6.23 76.1% False a
10 rs13480621 66,633,531 66,622,596-69,957,648 6.26 74.1% False a
11 rs13480851 7,106,276 7,106,276-7,133,854 6.23 67.3% True 20,21
11 rs13480851 18,664,287 18,012,274-18,776,572 6.90 76.8% True 20,21
11 rs13480915 24,340,180 - 5.97 64.7% True 20,21
11 rs13480915 84,210,490 84,186,523-84,210,490 6.39 71.2% True 20,21
11 rs13481191 100,981,257 - 6.05 66.5% True 20,21
12 rs13481191 17,813,143 - 6.51 77.8% True 20,21
12 rs3655333 29,314,512 29,245,634-29,342,877 6.26 70.0% True 20,21
12 gnf12.033.545 35,706,448 - 5.78 65.2% True 20,21
12 mCV23299449 40,033,960 - 6.60 73.7% True 20,21
12 rs6197363 46,205,386 46,195,413-46,672,638 6.55 67.3% True 20,21
13 rs6197363 82,973,404 - 6.64 83.5% True 20,21
13 rs13481961 98,370,936 97,388,131-98,516,414 5.52 60.6% True 20,21
13 rs13482032 118,459,784 116,568,685-118,459,784 7.66 93.9% False a
14 rs6291247 11,729,249 11,724,710-11,804,687 5.53 56.7% True 20,21
14 rs3678171 16,445,566 16,421,809-16,469,365 5.53 56.7% True 20,21
16 rs4163564 13.779,788 - 5.83 62.7% True b
18 rs13483379 57,799,450 - 6.96 76.3% True 20,21
18 rs3663770 67,730,210 67,730,210-67,748,515 6.59 72.4% True 20,21
18 rs13483493 89,985,557 - 6.87 79.6% True b
a this report
b unpublished crosses B6 × NOD and B6 × NZW by Paigen et al.
HAM QTL information for significant (P < 0.05) HDL peaks at HAM scores of 5.48. Positions are based on NCBI Mouse Build 36 position (bp) of 
1st SNP in 3-SNP window. The range is the locations of first and last SNP surrounding the peak that had a value <0.05.Page 6 of 12
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HAM genome scan for HDL in 81 strains of inbred miceFigure 4
HAM genome scan for HDL in 81 strains of inbred mice. X-axis = position in genome, chromosomes labeled. Y-axis = 
uncorrected HAM score, which is -log10(P value). Dotted lines indicate thresholds of genome-wide significance: HAM scores 
are 5.48, 4.46, and 3.48  for P = 0.05, 0.20, and 0.63
Significant one-way ANOVAs for HDL in (B6 × A)F2 malesFigure 5
Significant one-way ANOVAs for HDL in (B6 × A)F2 males. HDLD is concentration of plasma HDL (mg/dL). AA are A 
homozygotes, AB are heterozygotes, and BB are B6 homozygotes. A. Chr 8 ANOVA at 36.6 Mb (marker = D8Mit191, P < 
0.0001). B. Chr 8 ANOVA at 67.5 Mb (marker = D8Mit25, P < 0.0001).
BMC Genetics 2009, 10:81 http://www.biomedcentral.com/1471-2156/10/81strains for which SNPs are available are improving rap-
idly. Moreover, improved algorithms that account for
admixture and population structure will help minimize
false positives, such as the efficient-mixed model associa-
tion (EMMA) method of Kang et al. [18]. For example, we
think that the high number of false positives for HDL were
due to the enrichment of B6, DBA/2, and A genomes con-
tributed by the consomic and recombinant inbred lines,
and that the EMMA method of controlling for strain relat-
edness would have reduced these. In addition, the fact
that all but one of the false positives in our experiments
were in allelic association with a true QTL peak suggests
that the 3-SNP window is too restrictive and that using a
HAM algorithm with a haplotype-based window might be
a better approach. We subsequently tried HAM using a
haplotype based on a Hidden Markov Model and
imputed SNPs [27] and found that the percentage of false
positives was reduced. However, since the crosses were
already completed, we reported the results we obtained
with our initial analysis using a 3-SNP window. We also
expect that the Collaborative Cross [28] will further
improve the resolution of HAM in laboratory mice by dis-
rupting some of the pervasive linkage disequilibrium
found in the mouse genome. As a starting point for HAM
analyses, researchers can download and upload pheno-
type information on inbred lines from and to online
resources such as the Mouse Phenome Database http://
www.jax.org/phenome[29,30].
Conclusion
In sum, although HAM is not likely to detect all QTLs con-
tributing to a complex trait and is insufficient as a replace-
ment for traditional QTL mapping, we conclude that the
integrated method presented here is a powerful addition
to our toolbox for quantitative trait analysis. Instead of
conducting large scale expensive crosses, HAM can help
find new QTLs, which can then be verified using smaller
crosses designed to test specific regions of the genome.
Additionally, since such crosses are chosen based on their
haplotypes, this process can lead to the discovery of QTLs
that may not be found by the standard method of basing
parental strain choice on highly divergent phenotypes.
Methods
Animal housing & blood collection
Mice were obtained from The Jackson Laboratory and
housed under conditions meeting the guidelines issued by
the Association for Assessment and Accreditation of Lab-
oratory Animal Care. All animal protocols were approved
by The Jackson Laboratory's Animal Care and Use Com-
mittee. Mice were housed in 31 × 31 × 214 cm polycar-
bonate cages that were divided into 2 pens with no more
than 5 mice/pen (Thoren Caging Systems Inc.) in rooms
maintained at a 12:12 light:dark cycle and an ambient
temperature of 23°C. Each cage was pressurized and indi-
vidually ventilated (PIV) with HEPA filtered air supply
and exhaust. Mouse colonies were regularly monitored for
15 viruses, 17 bacterial species (including Helicobacter
spp., Pasteurella pneumotropica, and 2 Mycoplasma spp.),
ecto- and endo- parasites, and the microsporidium
Encephalitozoon cuniculi http://jaxmice.jax.org/health[31].
All mice were fed a regular chow diet (6% fat, 5K52 from
LabDiets®) and water ad libitum. About 200 uL of blood
for hematological analysis was obtained from 8-10 week
old mice in both the HAM strain panel and the (B6 ×
CBA)F2 intercross by retro-orbital bleeding. For lipid
analysis, plasma was separated from blood by centrifuga-
tion.
Phenotyping
Red blood cell count was measured using a Bayer ADVIA®
120 Hematology Analyzer from Siemens Diagnostics. A
SYNCHRON® CX5 Delta Clinical System chemistry ana-
Chromosome map of HDL HAM peaks and known HDL QTLsFigure 6
Chromosome map of HDL HAM peaks and known 
HDL QTLs. Black chromosome sections = 10 Mb. Marks to 
right of chromosomes denote HAM peaks. Gray areas to left 
of chromosomes indicate regions corresponding to the com-
bined 95% confidence intervals of all known HDL QTLs. 
Ovals are drawn around false positive HAM peaks; boxes 
(Chr 8) are drawn around HAM peaks outside of known 
HDL QTLs that tested positive in the (B × A)F2 test cross.
Chr 1 Chr 2 Chr 3 Chr 4 Chr 5 Chr 6 Chr 7 Chr 8 Chr 9 Chr 10
Chr 11 Chr 12 Chr 13 Chr 14 Chr 15 Chr 16 Chr 17 Chr 18 Chr 19Page 8 of 12
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Allelic association among HDL HAM peaksFigure 7
Allelic association among HDL HAM peaks. Allelic association among false positive HDL HAM peaks (on left) and true 
HDL HAM QTLs (on right).
BMC Genetics 2009, 10:81 http://www.biomedcentral.com/1471-2156/10/81lyzer from Beckman Coulter was used to measure the lipid
profiles of mouse plasma. The concentrations of high den-
sity lipoprotein cholesterol from these profiles were quan-
titatively determined using the SYNCHRON® Systems
Lipid Calibrator (HDLD assay).
Haplotype association mapping
The sex specific lipid and hematopoietic traits of inbred
lines of mice, including the B.A chromosome substitution
strains and the BxA and BxD recombinant inbred lines
(RILs), were measured. Using 4-15 mice per strain, we cal-
culated the sex specific trait means for HDL and RBC
(http://www.jax.org/phenome[30]; datasets "Stylianou
and Paigen" and "Peters1/MPD6202" respectively). HDL
values were log10 transformed. These trait data were input
into our analysis as vectors. A SNP panel consisting of
over 21,000 autosomal SNPs was compiled from SNP
resources including Wellcome Trust, Broad Institute, and
Perlegen, and missing SNPs were inferred from adjacent
SNPs (complete SNP panels with RBC and HDL trait
strain means and HAM results are available at http://
cgd.jax.org/datasets/phenotype.shtml[32]. For RBC, we
included 33 classic inbred strains in our strain panel; for
HDL, we included 32 classic inbred strains and added the
20 B.A chromosome substitution strains, 15 BxA RILs, and
14 RILs, for a total of 81 strains. These strain panels were
input into our analyses as genotype matrices.
We computed regression-based test statistics to measure
the strength of association between 3-SNP haplotypes and
averaged mean phenotypes to detect haplotype groupings
with significantly different mean phenotypes. Since the
segregation of strains into genotypic groups varies widely
over haplotype blocks, P values rather than the test statis-
tics were reported and used for comparisons among hap-
lotype blocks. All P values were transformed using -
log10(P value) to produce HAM scores for the scan plots.
We controlled type I error rate for multiple testing due to
genome-wide searching using family-wise error rate con-
trol [33]. Permutations were performed by shuffling the
phenotype data while keeping the genotype data intact.
The minimum P value was recorded for each permutation,
and percentiles of their distribution were used to provide
approximate multiple test-adjusted thresholds. The
genome-wide type I error thresholds were estimated based
on 1000 permutation tests. 3-SNP windows, or "peaks"
corresponding to P value thresholds adjusted for global
significance were defined as follows: P < 0.05 as signifi-
cant, P < 0.2 as highly suggestive, and P < 0.63 as sugges-
tive [34]. We estimated "peak stability" by calculating
bootstrap values per peak based on 1000 bootstraps. All
analyses were done in the MATLAB computing environ-
ment (The Mathworks, http://www.mathworks.com[35].
F2 intercrosses
We examined the strain haplotypes at the significant and
suggestive peaks and chose strains for intercrosses based
on which strains had different haplotypes. Phenotype dif-
ferences between strains were not considered. For RBC,
the C57BL/6J (B6) and CBA/J (CBA) haplotypes differed
at all of the 6 relevant peaks in females, so we set up a
small F2 intercross of B6 females crossed with CBA males.
The resulting F2 females (N = 108) were phenotyped for
RBC at 8 weeks old. For HDL, the B6 and A/J (A) haplo-
types differed at all 10 significant peaks that were not con-
firmed by published HDL QTLs. Because our lab had
already conducted a large (B × A)F2 intercross for kidney
disease [36], we used the plasma stored at -80°C to meas-
ure HDL and used the saved DNA from 292 males for gen-
otyping. (When these crosses were decided upon,
phenotyped, and tested at the HAM peaks of interest for
this study, the Chr 8 HDL QTLs were discovered here and
were novel. However, while this paper was in preparation,
the same (B × A)F2 cross DNA was subsequently geno-
typed at additional locations across the genome and was
published by Stylianou et al. [37] as a traditional genome-
wide QTL analysis in conjunction with an evaluation of
HDL QTLs in B.A chromosome substitution strains.)
Genotyping
Genomic DNA was extracted from the tail-tips of the F2
progeny using a standard phenol-choloform procedure.
SNPs flanking, within, or nearby HAM peaks of interest
were genotyped by the Allele Typing Service at The Jack-
son Laboratory in conjunction with KBiosciences Ltd. In 6
cases, microsatellite markers were used instead:
D1Mit373, D2Mit1, D8Mit191, D8Mit25, D11Mit48,
and D15Mit149. For these, genomic DNA was amplified
in PCR reactions with 0.200 mM of each dNTP, 0.132 uM
of each MIT marker primer, 1× AmpliTaq buffer, and
0.375 Units of AmpliTaq® DNA Polymerase (Applied Bio-
systems) under the following amplification conditions:
initial denaturation at 95°C for 5 minutes, 35 cycles of
95°C (30 seconds) + 55°C (30 seconds) + 72°C (1
minute), and a final elongation at 72°C for 7 minutes.
PCR products were visualized on 2% agarose gels and
scored by eye.
Statistical analyses
Intercross progeny were genotyped at markers flanking,
including, or nearby the HAM peak of interest. Using JMP®
by SAS, we tested each marker for correlations between
phenotype and genotype with one-way ANOVAs. We
tested the non-independence of the HAM peaks using an
analysis of "linkage disequilibrium" in GENEPOP, http://
genepop.curtin.edu.au[38,39]. Pairwise comparisons of
the 3-SNP haplotypes at the HAM peaks for each trait were
conducted by contingency table analysis using a MarkovPage 10 of 12
(page number not for citation purposes)
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GENEPOP, with 1000 permutations. A Bonferroni correc-
tion was applied to the results in each case to account for
multiple testing. For RBC, all HAM peaks above the sug-
gestive P < 0.63 threshold were tested for the non-random
association of their haplotypes with each other, while for
HDL, all significant HAM peaks above the significant P <
0.05 threshold were tested for the non-random associa-
tion of their haplotypes with each other.
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